Edward S. Rogers III, chairman of the board of directors of Rogers Communications, holds the American League Championship Series trophy after the Toronto Blue Jays defeated the Seattle Mariners in ...
A drug billed by Sanofi as a successor to its blockbuster inflammation and immunology blockbuster Dupixent is being prepared for phase 3 trials in asthma – even though it missed the mark in a midstage ...
Sanofi's oral BTK inhibitor tolebrutinib is heading towards an FDA decision in September as a potential treatment for multiple sclerosis (MS) after a priority review by the US regulator. Tolebrutinib ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback